newsfilter
← Latest News
Business Wire·

The Shuman Law Firm Investigates BioMimetic Therapeutics, Inc.

BOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm today announced that it is investigating potential claims against certain officers and directors of BioMimetic Therapeutics, Inc. (“BioMimetic” or the “Company”) (NASDAQ: BMTI). BioMimetic is a biotechnology company specializing in the development and commercialization of products to promote the healing of musculoskeletal injuries and diseases.